Regeneron Pharmaceuticals, Inc.
Anti-GITR antibodies and uses thereof

Last updated:

Abstract:

Provided herein are antibodies, and antigen-binding fragments thereof that specifically bind glucocorticoid-induced tumor necrosis factor receptor (GITR) and methods of using the same, including, e.g., methods of treatment using the same.

Status:
Grant
Type:

Utility

Filling date:

26 Jun 2020

Issue date:

16 Aug 2022